Palvella Therapeutics, Inc. (NASDAQ:PVLA) is held by 137 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 71,449 | 14.65% | $0.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 70,000 | 8.51% | $0.00 |
| Frazier Life Sciences Management, L.P. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 15,360 | 157.12% | $0.00 |
| BVF INC/IL | 31 Dec, 2025 | 0 | -282,240 | -24.30% | $0.00 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 354,525 | 1,015.98% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 10 | 0.00% | $0.00 |
| First Light Asset Management, LLC | 31 Dec, 2025 | 0 | 167,597 | 30.95% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | -45,213 | -13.08% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 65,960 | 13.33% | $0.00 |
| MPM BioImpact LLC | 31 Dec, 2025 | 0 | 138,322 | 205.16% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 283,211 | 206.35% | $0.00 |
| Samsara BioCapital, LLC | 31 Dec, 2025 | 0 | -104,817 | -50.00% | $0.00 |
| JENNISON ASSOCIATES LLC | 31 Dec, 2025 | 0 | 280,573 | 262.44% | $0.00 |
| Clio Asset Management LLC | 31 Dec, 2025 | 0 | 1 | 0.00% | $0.00 |
| Federated Hermes, Inc. | 31 Dec, 2025 | 0 | 28,991 | 8.55% | $0.00 |
| NEXTBio Capital Management LP | 31 Dec, 2025 | 0 | 82,686 | 0.00% | $0.00 |
| ALLIANCEBERNSTEIN L.P. | 31 Dec, 2025 | 0 | 269,027 | 0.00% | $0.00 |
| Blue Owl Capital Holdings LP | 31 Dec, 2025 | 0 | -14,741 | -15.47% | $0.00 |
| PERCEPTIVE ADVISORS LLC | 31 Dec, 2025 | 0 | -128,806 | -32.60% | $0.00 |